19 June 2013
Keywords: king, completes, elan, acquisition, discount, usa, pharmaceuticals
Article | 23 June 2003
The USA's King Pharmaceuticals has now completed the $750 million acquisition of Elan's primary care franchise. The deal, which had stalled ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.